Epidermal growth factor receptor tyrosine kinase inhibitors: current status and future perspectives in the development of novel irreversible inhibitors for the treatment of mutant non-small cell lung cancer / Galvani, Elena; Alfieri, Roberta; E., Giovannetti; Cavazzoni, Andrea; LA MONICA, Silvia; Galetti, Maricla; Fumarola, Claudia; Bonelli, Mara; Mor, Marco; Tiseo, Marcello; G. J., Peters; Petronini, Pier Giorgio; Ardizzoni, Andrea. - In: CURRENT PHARMACEUTICAL DESIGN. - ISSN 1381-6128. - 19:(2013), pp. 818-832. [10.2174/1381612811306050818]
Epidermal growth factor receptor tyrosine kinase inhibitors: current status and future perspectives in the development of novel irreversible inhibitors for the treatment of mutant non-small cell lung cancer
GALVANI, Elena;ALFIERI, Roberta;CAVAZZONI, Andrea;LA MONICA, Silvia;GALETTI, Maricla;FUMAROLA, Claudia;BONELLI, Mara;MOR, Marco;TISEO, Marcello;PETRONINI, Pier Giorgio;ARDIZZONI, Andrea
2013-01-01
File in questo prodotto:
| File | Dimensione | Formato | |
|---|---|---|---|
|
CPD2013.pdf
non disponibili
Tipologia:
Documento in Post-print
Licenza:
Creative commons
Dimensione
295.13 kB
Formato
Adobe PDF
|
295.13 kB | Adobe PDF | Visualizza/Apri Richiedi una copia |
I documenti in IRIS sono protetti da copyright e tutti i diritti sono riservati, salvo diversa indicazione.
